CC
AKRO

Centiva Capital’s Akero Therapeutics AKRO Stock Holding History

Centiva Capital’s Portfolio AKRO Stock Details AKRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-300
Closed -$10K – 1342
2022
Q3 		$10K Buy
+300
New +$4.59K ﹤0.01% 1400

Other funds holding AKRO

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Centiva Capital's AKRO Position: Q4 2022 in Review

Centiva Capital sold out of Akero Therapeutics (AKRO) in Q4 2022, closing a stake of 6,685 shares — an estimated $228K sold.

Centiva Capital first reported a position in AKRO in Q3 2022 and held it in 1 quarter. The position peaked at $228K in Q3 2022. 161 funds tracked by Wall St. Rank hold AKRO as of Q4 2022.

  • Centiva Capital reported no remaining Akero Therapeutics position as of Q4 2022 after selling out during the quarter.
  • Centiva Capital sold 6,685 Akero Therapeutics shares in Q4 2022, an estimated $228K.
  • Centiva Capital first reported a position in Akero Therapeutics in Q3 2022 and held it in 1 quarter.
  • Centiva Capital's Akero Therapeutics position peaked at $228K in Q3 2022.
  • 161 funds tracked by Wall St. Rank held Akero Therapeutics as of Q4 2022.

Based on Centiva Capital's 13F filing for Q4 2022, filed 14 Feb 2023.